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Introduction: Transcranial Direct-Current Stimulation is one of the most challenging version of 
non-invasive brain stimulation. Although it has promised effects on drug-cravings, it has not been 
approved by FDA as an intervention.The purpose of this study was to investigate the effectiveness 
of tDCS on reducingmethamphetamine craving. 
Method: This study was a quasi-experimental design with the pre-test, post-test and control group. 
The statistical population included all the methamphetamine users who were referred to the 
HematPayrovan Institute for treatment in 2019. The sample population were 60 males assigned 
randomly into two groups of experimental and control group. We applied 20 minutestDCS (2 Ma, 
Anode F4/Cathode FP1) for experimental group. Data were collected using the Individual Student 
Assessment Plan (ISAP), The Leeds Dependence Questionnaire (LDQ), and Desires for drug 
questionnaire (DDQ). The data were analyzed through multivariate analysis of covariance 
(MANCOVA). 
Results: The result showed that t DCS significantly decreases methamphetamine craving in the 
experimental group (P<0.03). 
Discussion: This finding has important implications pertaining the education and mental health of 
methamphetamine users. Based on the results, repeated DLPFC stimulation could be a promising 
approach for therapeutic intervention in decreasing methamphetamine craving.   
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  Introduction 
  Drug addiction, also known as 
substance use disorder (SUD), is a severe 
threat to physical and psychological health 
of individuals, which affects at least 275 
millions of people all over the world (1,2). 
This medical condition is defined as the 
compulsive active use of substances 
regardless of the potential harms. The 
diagnostic criteria include withdrawal 
symptoms, craving, physical and mental 
illness, etc. (3). Methamphetamine is an 
extremely addictive psycho-stimulant drug 
that has developed early in the 20th 
century from its parent drug, 
amphetamine, and was used originally in 
nasal decongestants and bronchial inhalers 
(4). The clinical effects of 
methamphetamine include increased 
alertness and aggression, loss of appetite 
and insomnia. (5). Medically it may be 
indicated for the treatment of attention 
deficit hyperactivity disorder and as a 
short-term treatment for weight loss (6,7), 
but these uses are limited and it is rarely 
prescribed.Also, the prescribed doses are 
far lower than those typically abused (8). 
This substance is mostly popular among 
young adults, due to its availability, long 
duration of psychoactive effects, and 
comparatively low costs (4,7). 
Methamphetamine is a powerful, highly 
addictive stimulant that affects the central 
nervous system and the monoamine 
neurotransmitter system of the brain (9).  
Addictions involve persistent, compulsive, 
and uncontrolled behaviors that are both 
maladaptive and destructive (1,3). The role 
of mesocorticolimbic dopaminergic and 
glutaminergic pathways, intracellular 
mechanisms, and relevant brain regions in 
compulsive drug drive and inhibitory 
dyscontrol have been the focus of these 
sections on drug relapse (9,10). Most kinds 
of SUDs are generally considered to 
originate from abnormality in dopamine 
(DA) system (11) and increase 
extracellular concentrations of mesolimbic 
dopamine (12,13). Meth-craving is 
stronger comparative to other drugs 
probably based on its high speed of 
inducing mesolimbic dopamine (10).Its 
abstinence period is longer than others due 
to its recurrent cravings which made the 
treatment so hard (14). The bunch of 
imaging studies have revealed that the 
repeated use of amphetamine-like 
substances will down-regulate DA release 
and DA receptor availability (14) which 
results in the attenuation of projections to 
the cortical areas such as the dorsolateral 
prefrontal cortex (DLPFC), and 
orbitofrontal cortex (15). These regions of 
brain are responsible for executive control 
functions or salience attribution to the 
external stimuli (16). This might explain 
why the abusers are hardly able to control 
the craving and consumption of drugs 
(16,17). In general, the dysfunction of 
dopamine system plays a central role in 
drug addiction (14) and this notion has 
inducted the development of 
neurobiological treatments including brain 
stimulations. 
Transcranial direct current stimulation  
(tDCS) is the last generation of non-
invasive brain stimulation )NIBS(which 
has broad applications in cognitive 
enhancement and treatments (18).tDCS 
modulates brain activity noninvasively 
(18,19). tDCS is of major current 
contribution to the treatment of different 
brain disorders such as stroke, epilepsy, 
aphasia after stroke, depression, and binge 
eating disorder (20-23). In other 
applications, tDCS has been successfully 
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employed on healthy subjects e.g. to 
increase motor function (24) and cognitive 
brain function (25). The findings of the 
studies indicate that the anode tDCS could 
increase excitability in motor areas, while 
cathodaltDCS induces inhibition (18). 
Although inducing direct action potential 
is not imagined because of its weak 
electric currency, it could raise/lower 
neural threshold through 





permeability in a polarity 
dependent manner (26). Its restricted 
penetration is not only considered as 
limitation, but also advantageous element 
which could satisfy fastidious psychiatrics 
for its restricted side effects (18,19).  
Numerous studies suggest the effects of 
brain stimulation on the dopamine system. 
Some studies show that tDCS could induce 
DA release (27). Likewise, DA transporter 
accessibility in caudate nucleus goes up 
after a high-frequency repetitive 
transcranial magnetic stimulation (rTMS) 
on DLPFC in a recent case study (28). 
Moreover, tDCS on bilateral DLPFC 
elicits DA increase in the same region as 
well (29). A meta-analysis investigated the 
effect of NIBS toward DLPFC on craving 
for food or stimulants and reported a 
medium treatment effect (30). These 
findings may be indicative of the 
effectiveness of brain stimulation in 
reducing meth craving through changes in 
DA. Accordingly, and considering the 
need for effective therapeutic approaches 
to reduce meth craving, this study 
investigated the effects of repeated tDCS 
over the DLPFC on decrease meth craving. 
 
    Method  
    This research has been conducted by a 
semi-experimental method with pretest-
posttest design and control group. In this 
research, treatment methods have been 
considered as independent variables at two 
levels (tDCS and no intervention), and 
meth craving has been considered as 
dependent variable. The research 
population includes all the 
methamphetamine users who were referred 
to the HematPayrovan Institute for 
treatment in 2019. The sample includes 60 
methamphetamine users who have been 
selected by convenience sampling and 
randomly assigned to experimental and 
control groups. The sample size was 
determined by using the following 
formula. As the population was specific 
and limited, the sample size was obtained 
by the following formula with an accuracy 
of 5% and a confidence level of 95%.  
 
The inclusion criteria included: passing 
SCID-8 as an approved drug-dependent 
criterion, history of methamphetamine use 
at least 6 months based on DSM-V 
criteria, use at least 3 times per week over 
the past 6 months, male with at the age of 
21-50 years. The exclusion criteria 
included: female gender, history of brain 
trauma, epilepsy, brain surgeries/metal 
implants or tumors.  
Data collection was done by using the 
following tools: 
- Individual Student Assessment Plan 
(ISAP):  ISAP is a standard demographic 
questionnaire that is initiated by Iranian 
National Center for Addiction Studies 
(INCAS) for evaluating demographic 
characteristics and different addiction-
related dimensions. 
- The Leeds Dependence Questionnaire 
(LDQ): LDQ is a self-reported, 10-item 
questionnaire, validated to be used in 
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addiction and psychiatric settings for 
alcohol and opiate consumers to measure 
substance dependence severity [19, 20]. 
The LDQ (31) is composed of 10 items, 
which are scored with 4 digits: 0-1-2-3 (0 
= never, 1 = sometimes, 2 = often, 3 = 
nearly always) measuring the severity of 
dependence upon substances, independent 
of the pharmacological properties or the 
quantity of substances overused. The 
operational definitions given to the 10 
cognitive and behavioral markers of 
substance dependence by Raistrick et al. 
(31), representing the ICD-10 and DSM-
IV criteria for substance dependence, are 
pre-occupation, salience, compulsion to 
start, planning, maximize effect, narrowing 
of repertoire, compulsion to continue, 
primacy of effect, constancy of state and 
cognitive set (items from 1 to 10, 
respectively). The LDQ total score 
increases with the degree of substance 
dependence, but no cut-off score 
indicating dependence has been identified. 
High LDQ scores are associated with 
cognitive preoccupation with substance 
use, a compulsion to use, continual use, 
planning and organizing future use, 
maximization of the subjective experience 
of substance use, a reduced repertoire of 
behaviour with the primacy of substance 
use and substance use as an existential 
coping strategy. 
- Desires for drug questionnaire (DDQ): 
The original DDQ includes 13 questions 
for three main craving components, desire 
and intention to drug use (questions 1, 2, 4, 
6, 10, 13 and 14), negative reinforcement 
(questions 5, 9, 11 and 12), and control 
(questions 3 and 8). We restored the 
question, which had been excluded from 
the final questionnaireby Franken, et al 
(2002), in order to increase the internal 
consistency of its respective component, in 
our questionnaire (R: question 7). 
Participants answer questions on a seven-
step Likert-scale answer sheet based on 
what he/she feels or thinks at the moment. 
The items were rated as follows: 1) not at 
all; 2) mild; 3) mild to moderate; 4) 
moderate; 5) moderate to severe; 6) severe 
and 7) approximately complete. 
- Transcranial direct current 
stimulation  (tDCS) 
Direct currents of 2 mA generated by an 
electrical stimulator were applied through 
a pair of saline-soaked sponge electrodes 
(7 × 5 cm) for 20 min. In both, active and 
sham conditions, to stimulate the left 
DLPFC, the anode electrode was vertically 
positioned over F4 the cathodal reference 
electrode was horizontally positioned over 
FP1. The electrode placement and method 
of localization is in accordance with 
previous tDCS studies, and has shown to 
produce significant effects on reducing 
cravings in a range of studies. For sham 
stimulation, the person receiving the tDCS 
did not know that they are not receiving 
prolonged stimulation. The experimenter 
who applied tDCS was blind to the study 
hypotheses but not to the tDCS condition 
(active vs sham).All of participants could 
tolerated repeated sessions with no major 
side effect and none of them given up for 
this reason, Most prevalent side effects are 
numbness or tingling 20%, headache 14%, 
sleepiness 5%.  
Before intervention, participants were 
divided in test and sham group 
accidentally in a double-blinded manner 
and were hidden throughout the 




















 day in order to have cross 
sectional assessment of craving through 
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and after the research. Consequently, we 
had 4 variables (3 component of DDQ and 
1 from LDQ) indicating four dimensions 
of Meth-craving from 2 separate groups. 
Data were analyzed in SPSS 21 software. 
 
   Result 
   We start with 60 Meth-dependent males 
but only 46 people could complete the 
study. According to table 1 the test group 
contains 23 males (28 ± 6) and the control 
one has also 23 males (38 ± 8). Their first 
age of drug consumption was 21± 5 and 24 
± 7 respectively. Both groups have the 




Table 1: Demographic descriptive information of test and control group 
  Experimental group Control group 
Age  28 ± 6 31 ± 8 
Education level  10 ± 2 10 ± 2 
Marital status 
Married 4.4% 22% 
single 86.9% 60% 
Divorced 8.8% 17.4 % 
Injection history  13% 26% 
Record of 
imprisonment 
 26% 26% 
History of drug 
trafficking 
 39% 35% 
Methamphetamine 
abuse 




Number of years of 
consumption 
7 ± 4.5 7 ± 4.5 
Nicotine and Tobacco 
 
Number of years of 
consumption 
14 ± 7 11 ± 8 
Opioids 
Number of years of 
consumption 
2 ± 2.5 2 ± 3 
Alcohol 
Number of years of 
consumption 
9 ±7 8 ± 8 
 
Table 2 presents the mean and standard 
deviation of quality of life for patients  
 
 
affected by macular degeneration in 
control and experimental groups based on 
the pretest and posttest results.  
 
Table 2: Mean and standard deviation of depression scores of control and experiment groups in pretest  
and posttest 
Control group  Experimental group   Quality of life 
SD Mean SD Mean   
18.04 40. 14 15.98 41.51 Pretest DDQ1 
15.12 28.68 1.43 6.78 Posttest  
16.97 31.36 18.86 34.89 Pretest DDQ2 
13.88 18.89 1.92 7.49 Posttest  
15.59 21.41 22.31 25.98 Pretest DDQ3 
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9.56 10.33 6.49 9.61 Posttest  
5.35 15.87 5.38 16.17 Pretest LDQ 
4.94 10.30 2.74 3.96 Posttest  
 
As seen in the table, there is asignificant 
difference between the mean posttest 
scores of DDQ and LDQ in the control and  
 
experimental groups; in the experimental 
group, the mean scores of DDQ and LDQ 
in posttest are lower than the scores of 
pretest.  
In order to observe the assumptions of 
parametric tests, Box and Levene’s tests 
were used before using the parametric test 
of multivariate analysis of covariance. The 
results of the Box test were not significant 
for any of the variables; based on this test, 
the presumption of homogeneity of 
variance/covariance matrixes have been 
well observed (Box=3.17, F=0.88, 
P=0.29). According to the results of 
Levene’s test, the presumption of equality 
of intergroup variances has been observed 
for posttest and its insignificant results for 
all variables (p>0.05). P-value was not 
lower than 0.05 in One-Sample 
Kolmogorov-Smirnov Test, which means 
that the distribution is not normal then 
non-parametric evaluation is needed. So, 
multivariate analysis of covariance can be 
done. The results of Wilks Lambda 
showed that there is a significant 
difference between the posttest of the 
studied groups in terms of at least one of 
the dependent variables (Wilks Lambda= 
0.74, F=4.89, P ˂ 0.001). According to the 
results of eta-squared, it was found that the 
difference between the two groups is 
significant regarding the dependent 
variables and this difference in posttest is 
73% based on Wilks Lambda (eta 
squared=0.73); i.e. 73% of the variance is 
related to the difference between the two 
groups which results from the mutual 
effect of dependent variable of DDQ and 
LDQ.  
 
Table 3. The results of the analysis of covariance 
Eta 
squared 




0.20 11.03 6555.55 1 6555.55 Group DDQ1 
  594.61 44 26162.62 Error  
0.10 4.95 2843.81 1 2843.81 Group DDQ2 
  574.86 44 25293.73 Error  
0.00 0.02 11.31 1 11.31 Group DDQ3 
  2.83 44 240.94 Error  
0.17 8.84 774.28 1 774.28 Group LDQ 
  87.57 44 3853.18 Error  
   
As presented in table 3, with the controlled 
effect of pretest, there is a significant 
difference between the posttest results of 
experimental and control groups in terms 
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of the mean scores of DDQ1 (F=11.03), 
DDQ2 (F=4.95), and LDQ (F=8.84), (P ˂ 
0.05). In other words, in posttest of the 
experimental group, tDCS has 
significantly decreased DDQ and LDQ in 
methamphetamine users.  
Discussion and Conclusion  
The aim of this study was to determine the 
effectiveness of tDCS in reducing meth 
craving. According to the findings of the 
study, tDCS had an effect on reducing 
meth craving in methamphetamine users, 
which is consistent with the results of 
previous studies (27-30, 33, 34). In this 
study the best montage for meth craving 
which was 2 ml A, 20 min on Anode F4 
and cathode FP1which was on consensus 
of pervious researches. Fregni et al. (33) 
showed that anodal stimulation of both left 
and right DLPFC with active, but not 
sham, tDCS reduced smoking craving 
compared to baseline. Furthermore Boggio 
et al. (34) found that both anodal 
left/cathodal right and anodal 
right/cathodal left tDCS significantly 
decreased alcohol craving compared to 
sham stimulation. Finally, this effect was 
also found for marijuana craving. Boggio 
et al. (2010) observed that right anodal/left 
cathodaltDCS of DLPFC reduced craving 
for marijuana. 
Different underlying mechanisms have 
been suggested for tDCS considering its 
varied effects. The wide variation of its 
effects on the same disorders which 
decrease its significance is also explained 
by different levels of extracellular 
dopamine. tDCS was proposed to have the 
potential ability to act through different 
neural mechanisms in different time 
courses. Its Anode’s after effect is 
attributed to cell membrane permeability 
to positive ions which could reduce neural 
threshold excitability (27). Neuro-
modulatory effects of tDCS, especially on 
dopamine, would be the first candidate for 
its durable effects on drug-craving. Since 
tDCS has enough time to neutralize meth-
induced dopamine receptors gradually 
from down-regulation (29), this would be a 
good explanation for its neuro-plastic 
effects on addiction-induced neuro-
adaptations. 
Often tDCS studies had targeted the 
DLPFC area as a current location for the 
stimulation brain. It is well indicated that 
the DLPFC is critically involved in the 
processing of drug craving. Furthermore, 
drug-dependent individuals exhibit lower 
resting and metabolic activity in PFC (28). 
The DLPFC integrates cognitive, 
emotional, and motivational information in 
order to make a decision and regulate 
emotion, motivation, and internal state and 
uses this information to regulate drug 
seeking and drug avoiding behaviors 
(21,28). According to these findings, and 
considering mechanisms of anodal tDCS 
in facilitating spontaneous neuronal 
activity and reinforcing local plasticity 
(30), we conjecture that anodal stimulation 
enhances DLPFC activity, which may 
inhibit drug-seeking behavior. 
According to conceptualization of drug 
addiction, the craving stage involves 
neuro-plastic changes in the brain reward 
system, stress, and executive function 
systems (33). Here, PFC regions play a 
critical role, especially the DLPFC. 
Deficits in executive functionsin 
individuals with SUD are reflected by 
decreases in frontal cortex activity that 
interfere with decision-making, self-
control, emotionregulation, and planning, 
which lead tocompulsive drug use and 
deficiency of control in addiction (21). On 
the basis of previous studies and the 
present results, we speculate that 
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stimulation of the DLPFC with anodal 
tDCS may have increased excitability and 
functional connectivity in this region and 
other networks involved in addiction and 
thereby resulted in increased control of 
drug-seeking behavior. 
tDCS anodal excitation could play a semi-
natural role in neural activities because of 
its gentle and gradual influences. Its 
potentiality of being repeated provides 
enough time for changing receptor 
activities (33). This opportunity is not 
available for any drug because of their 
limitations due to their side effects (34). 
Additionally, drugs lead to a similar neuro-
adaptation with is proposed as the basic 
underlying mechanism of addiction. Other 
NIBS such as rTMS could not be repeated 
because of its strong annoying effects. 
Our findings indicated that active 
prefrontal tDCS reduces craving at meth 
users. This may reflect the role of the 
prefrontal cortex in top-down craving 
modulation. These results offer initial 
promising information to support further 
studies investigating tDCS as a clinical 
application for meth craving in 
methamphetamine users. 
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